Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

DA-EPOCH-R regimen

(… REH-jih-men)

An abbreviation for a chemotherapy combination used to treat certain types of non-Hodgkin lymphoma. It includes the drugs etoposide phosphate, prednisone, vincristine sulfate (Oncovin), cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), and rituximab. During each treatment cycle, the doses of some of the drugs may be increased or decreased to allow the patient to receive the dose that works the best with the fewest side effects. Also called DA-EPOCH-R, dose-adjusted EPOCH-R, and dose-adjusted EPOCH-R regimen.

DA-EPOCH-R regimen

Search NCI's Dictionary of Cancer Terms